by Jordana Choucair | Jan 24, 2022 | Life Sciences
The FDA is weighing whether to limit the authorization of monoclonal antibody treatments from Eli Lilly & Co. and Regeneron Pharmaceuticals Inc., which haven’t proved effective against the Omicron variant. According to a person familiar with the process,...
by Jordana Choucair | Jan 24, 2022 | Life Sciences
Pfizer Inc. CEO Albert Bourla said the drugmaker hopes to offer an annual COVID-19 vaccine because it “will not be a good scenario” if people have to get more frequent booster shots. He said Pfizer aims to develop a vaccine that “covers omicron and...
by Jordana Choucair | Jan 24, 2022 | Health IT
A study conducted by Cigna found that virtual care can reduce unnecessary ER or urgent care visits by 19 percent. The study, conducted alongside its telehealth arm MDLive, found that virtual urgent care visits reduced duplication of care by 16 percent compared to...
by Jordana Choucair | Jan 24, 2022 | Access & Coverage
Georgia Governor Brian Kemp filed a lawsuit against the Biden administration to force the reinstatement of the state’s Medicaid waiver. The Trump administration approved the plan, which would have imposed work requirements and premiums. Last month, HHS informed...
by Jordana Choucair | Jan 21, 2022 | Health IT
A new CB Insights report found that the digital health industry raised a record $57.2 billion in 2021, an increase of 79 percent since 2020. Telehealth received the most funding at $17.6 billion, followed by health IT startups ($8.6 billion), mental wellness and...
by Jordana Choucair | Jan 21, 2022 | Access & Coverage
The Supreme Court rejected the latest attempt to block the six-week abortion ban in Texas. Abortion providers had asked the Supreme Court to send the case back to a federal district court, where the judge presiding over their challenge had previously blocked the Texas...
Recent Comments